Claims
- 1. (20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol in crystalline form.
- 2. The crystalline form of claim 1 having molecular packing arrangement defined by orthorhombic space group P2(1)2(1)2(1) and unit cell dimensions a=6.6A°, b=15.5A°, c=20.1A°, α=90°, β=90° and γ=90°.
- 3. The three dimensional structure for (20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol as defined by the parameters set forth in claim 2.
- 4. A method of purifying (20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol, comprising the steps of:
(a) boiling a solvent selected from the group consisting of acetone, ethyl acetate, isopropanol, chloroform, dichloromethane and diethyl ether under inert atmosphere; (b) dissolving a product containing (20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol to be purified in said solvent; (c) cooling said solvent and dissolved product below ambient temperature for a sufficient amount of time to form a precipitate of (20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol crystals, and (d) recovering the (20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol crystals.
- 5. The method of claim 4 including the further step of allowing said solvent and dissolved product to cool to ambient temperature prior to cooling below ambient temperature.
- 6. The method of claim 4 wherein said inert atmosphere is an argon atmosphere.
- 7. The method of claim 4 wherein said solvent and dissolved product is cooled to between about 35° F. to about 45° F.
- 8. The method of claim 4 wherein the step of recovering comprises filtering.
- 9. The method of claim 4 including the further step (e) comprising repeating steps (a) through (d) using the recovered crystals from step (d) as the product of step (b).
CROSS REFERENCE TO RELATED APPLICATIONS
[0001] This application is based on and claims priority from U.S. Provisional Patent Application No. 60/341,138 filed Dec. 13, 2001.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60341138 |
Dec 2001 |
US |